BW-A 58C

DB06740ExperimentalSmall molecule

BW-A 58C, also known as 2-(4-tert-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone, is an experimental naphthoquinone antimalarial drug which undergoes extensive alkyl hydroxylation to a single t-butylhydroxy metabolite in man in vivo and also in human...

Formula / weight: C₂₀H₂₄O₃ · 312.409 g/mol (avg)
Code names: 58C80 · BW-A 58C

Resolves to

Compound

CAS94015-46-0PubChem146797

Structure

InChIKeyNWCVRXADYNRXCT-UHFFFAOYSA-NSMILESCC(C)(C)C1CCC(CC1)C1=C(O)C(=O)C2=CC=CC=C2C1=O

What you can answer from here — as of July 03, 2026

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of BW-A 58C, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account